Concepedia

Author

Raphael Koch

Dana-Farber Cancer InstituteORCID

Also Known As

Koch, R., R J Koch, R Koch, R. Koch, Raphael Koch

70

Publications

2.4K

Citations

17

H-Index

40

Concepts

All Affiliations

Dana-Farber Cancer InstituteHarvard UniversityUniversitätsmedizin GöttingenUniversity of GöttingenBroad Institute
RK

About

Raphael Koch is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and systems biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

867

2

Engineering

1

1

302

3

Health Sciences

1

1

13

4

Natural Sciences

1

1

36

5

Biochemistry

1

1

36

Raphael Koch

×

19

Publications

1.9K

Citations

15

H-Index

YearCitations

Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3

Thiha Aung, Bjoern Chapuy, Daniel Vogel,

Proceedings of the National Academy of Sciences

2011

348

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

Elizabeth C. Townsend, Mark A. Murakami, Alexandra Christodoulou,

Cancer Cell

2016

302

Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma

Steven M. Horwitz, Raphael Koch, Pierluigi Porcu,

Blood

2017

274

Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration

Bjoern Chapuy, Raphael Koch, Ulf K Radunski,

Leukemia

2008

154

Populational equilibrium through exosome-mediated Wnt signaling in tumor progression of diffuse large B-cell lymphoma

Raphael Koch, Martin Demant, Thiha Aung,

Blood

2014

122

Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone

Raphael Koch, Thiha Aung, Daniel Vogel,

Clinical Cancer Research

2015

120

DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas

Yonghan He, Raphael Koch, Vivekananda Budamagunta,

Journal of Hematology & Oncology

2020

118

Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models

Samuel Y. Ng, Noriaki Yoshida, Amanda L. Christie,

Nature Communications

2018

111

ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drug

Bjoern Chapuy, M. V. Panse, Ulf K Radunski,

Haematologica

2009

90

Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas

Raphael Koch, Amanda L. Christie, Jennifer L. Crombie,

Blood

2018

59

Page 1